Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.47 | N/A |
| PEG Ratio (TTM) | -0.91 | N/A |
| P/S Ratio (TTM) | 2.74 | N/A |
| P/B Ratio (TTM) | 5.73 | N/A |
| P/FCF Ratio (TTM) | 28.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 58.51 | N/A |
| Price to 5YR AVG FCF Ratio | 46.39 | N/A |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 16.14% | N/A |
| ROE (TTM) | 35.68% | N/A |
| Net Profit Margin (TTM) | 14.80% | N/A |
| ROIC 5YR AVG | 31.59% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.22% | 674.71% | 497.52% |
| Revenue | 8.22% | 1.40% | 16.05% |
| Net Income | 16.95% | 683.09% | 504.20% |
| Cash Flow | -58.42% | -16.18% | 1,021.47% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | N/A |
| Quick Ratio (TTM) | 1.61 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 6.68 | N/A |
| LTL to 5YR AVG FCF | 0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.06% | N/A |